Breast-conserving therapy for ductal carcinoma in situ of the breast: The French Cancer Centers' experience

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 4, 2002, Pages 868-879

  Cutuli, Bruno ^a,k   Cohen Solal le Nir, Christine ^b   De Lafontan, Brigitte ^c   Mignotte, Hervé ^d   Fichet, Virginie ^e   Fay, Renaud ^f   Servent, Véronique ^g   Giard, Sylvia ^g   Charra Brunaud, Claire ^h   Lemanski, Claire ⁱ   Auvray, Hugues ^j   Jacquot, Stéphane ⁱ   Charpentier, Jean Christophe ^f  

^a Department of Radiation Oncology   (France)

^b CENTRE RENÉ HUGUENIN   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

^d CENTRE LÉON BÉRARD   (France)

^e INSTITUT PAOLI CALMETTES   (France)

^f MRC Statistics   (France)

^g CENTRE OSCAR LAMBRET   (France)

^h CENTRE ALEXIS VAUTRIN   (France)

ⁱ CENTRE VAL D AURELLE   (France)

^j CENTRE JEAN PERRIN   (France)

^k Polyclinique de Courlancy ^*  (France)

more..

Author keywords

Breast cancer; Breast conserving therapy; Ductal carcinoma in situ; Local recurrence; Radiotherapy; Young age

Indexed keywords

IRRADIATION; RADIOTHERAPY; REGRESSION ANALYSIS; SURGERY;

EXCISION QUALITY;

TUMORS;

ADULT; AGE; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER CENTER; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; COMEDO; CONFIDENCE INTERVAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRANCE; GENDER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; METASTASIS; PAPILLOMA; PRIORITY JOURNAL; QUALITY CONTROL; REGRESSION ANALYSIS; RISK ASSESSMENT; SURGICAL TECHNIQUE; TIME; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FRANCE; HUMANS; MIDDLE AGED; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037100126     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02834-1     Document Type: Article

References (103)

1. Ductal carcinoma in situ of the breast
2. Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999
3. The diagnosis and management of ductal carcinoma in situ of the breast
4. Ductal carcinoma in situ (DCIS) of the breast: Evolving perspectives
5. Outcome after invasive local recurrence inpatients with ductal carcinoma in situ of the breast
6. Risk factor for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ: Analysis of European Organisation for Research and Treatment of Cancer trial 10853
7. Ductal carcinoma in situ of the breast: Results of conservative and radical treatments in 716 patients
8. The natural history of ductal carcinoma in situ: Implications for clinical decision making
9. Surgical overview of the treatment of ductal carcinoma in situ
10. Predictors of local recurrence after treatment of ductal carcinoma in situ: A meta-analysis
11. Intraductal breast carcinoma: Review of a multicenter series of 350 cases
12. Van Nuys experience by treatment
13. The management of ductal carcinoma in situ of the breast
14. Analysis of 676 ductal carcinoma in situ (DCIS) of the breast from 1971 to 1995: Diagnosis and treatment - The experience of one institute
15. Breast carcinoma in situ in 167 women: Incidence, mode of presentation, therapy and follow-up
16. Linköping experience
17. Carcinoma in situ of the female breast: 10-year follow-up results of a prospective nation-wide study
18. Lagios experience
19. Ductal carcinoma in situ detected in the mammographic era: An analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy
20. Résultat du traitement par chirurgie conservatrice et irradiation de 132 carcinomes canalaires in situ non palpable du sein
21. Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy
22. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS)
23. Evaluation des facteurs prédictifs des récidives locales, en particulier de l'index de Van Nuys, dans les carcinomes intracanalaires du sein: Étude de 166 cas avec traitement conservateur et revue de la littérature
24. Treatment of subclinical ductal carcinoma in situ by local excision and surveillance: A personal experience
25. Controversies in the treatment of ductal carcinoma in situ
26. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer
27. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17
28. Pathologic findings from National Surgical Adjuvant Breast Project (NSABP): Eight-year update of protocol B-17 - Intraductal carcinoma
29. Radiotherapy in breast-conservative treatment for ductal carcinoma in situ: First results of the EORTC randomized phase III trial 10853
30. Risk factor for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ: Analysis of European Organisation for Research and Treatment of Cancer trial 10853
31. Reasons of non-entry of patients with DCIS of the breast into a randomised trial (EORTC 10853)
32. Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast conserving treatment for DCIS
33. Current concepts in the detection and treatment of the earliest of the early breast cancers
34. Florence experience
35. Non invasive breast carcinoma: Results of a national survey by the American College of Surgeons
36. Ten-year follow-up of breast carcinoma in situ in Connecticut
37. Le traitement des cancers intracanalaires
38. Breast carcinoma in situ
39. Three dimensional imaging of mammary ductal carcinoma in situ: Clinical implications
40. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ
41. Microcalcifications associated with ductal carcinoma in situ: Mammographic-pathologic correlation
42. Management of ductal carcinoma in situ
43. Subclinical ductal carcinoma in situ of the breast: Treatment with conservative surgery and radiotherapy
44. Recent trends of in situ carcinoma of the breast and mammographic screening in the Florence area, Italy
45. Incidence of and treatment for ductal carcinoma in situ of the breast
46. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: A dilemma
47. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: Patterns of failure and 10 years results
48. Management of screen detected ductal carcinoma in the female breast
49. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation long-term outcome and prognostic significance of patient age and margin status
50. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomized trials
51. Ductal carcinoma in situ of the breast: Progress and controversy
52. Nottingham experience
53. The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ
54. Breast-conserving therapy for patients with ductal carcinoma in situ
55. The influence of margin width on local control of ductal carcinoma in situ of the breast
56. Ductal carcinoma in situ of the breast from a population-defined cohort: An evaluation of new histopathological classification systems
57. Predictors of local recurrence following excision alone for ductal carcinoma in situ (DCIS)
58. In situ ductal carcinoma of the breast: Analysis of clinical presentation and outcome in 156 consecutive cases
59. Les récidives après traitement des carcinomes intracanalaires du sein
60. The influence of young age, and positive family history of breast cancer on the prognosis of ductal carcinoma in situ treated by excision with or without radiation therapy or by mastectomy
61. Duct carcinoma in situ: Predictors of local recurrence and progression in patients treated by surgery alone
62. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
63. Breast conservation therapy for intraductal carcinoma of the breast
64. Prognostic factors in ductal carcinoma in situ of the breast: Results of a retrospective study of 575 cases
65. Ductal carcinoma in situ of the breast: Results of treatment by conservative surgery and definitive irradiation
66. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history
67. Relationship of family history and outcome after breast conservation therapy in women with ductal carcinoma in situ of the breast
68. Institut Curie experience
69. An international collaborative study: 15-year experience
70. Ductal carcinoma in situ: Long-term results of breast conserving therapy
71. Mortality among women with ductal carcinoma in situ of the breast in the population-based Surveillance, Epidemiology and End Results program
72. Heterogeneity of duct carcinoma in situ (DCIS): Relationship of grade and subtype analysis to local recurrence and risk of invasive transformation
73. Regional differences in the incidence and treatment of ductal carcinoma in situ of the breast
74. Consensus conference on the classification on ductal carcinoma in situ
75. Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast
76. Ductal carcinoma in situ: A proposal for a new classification
77. Immunohistochemical evaluation of biological markers in mammary carcinoma in situ: Correlation with morphological features and recently proposed schemas for histological classification
78. Evaluation and management of high risk and premalignant lesions of the breast
79. Use of prognostic index for breast ductal carcinoma in situ: Is excision margin status still the most crucial factor in predicting disease recurrence?
80. The fourth EORTC DCIS consensus meeting (Château Marquette, Heemskerk, The Netherlands 23-24 January 1998) conference report
81. Developing a prognostic index for ductal carcinoma in situ of the breast: Are we there yet?
82. A prognostic index for ductal carcinoma in situ of the breast
83. Ductal carcinoma in situ: Introduction of the concept of ductal intraepithelial neoplasia
84. Ductal carcinoma in situ of the breast: Histological classification and genetic alterations
85. Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification: A study of 127 cases - Correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity
86. Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experience
87. Histological type and marker expression of the primary tumor compared with its local recurrence after breast conserving therapy for ductal carcinoma in situ
88. Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease
89. Conservative surgery and radiation therapy for ductal carcinoma in situ: Overview
90. Intraductal carcinoma of the breast: Pathologic features associated with local recurrence in patients treated with breast-conserving therapy
91. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation: Correlation of pathologic parameters with outcome of treatment
92. The classification of ductal carcinoma in situ and its association with biological markers
93. A long-term comparative study of the ability of five classifications of ductal carcinoma in situ of the breast to predict local recurrence after surgical excision
94. A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): Correlation with grade of associated invasive disease
95. Ductal carcinoma in situ of the breast: A proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression
96. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation: Correlation of pathologic parameters with outcome of treatment
97. Long-term follow-up of women with ductal carcinoma in situ treated with breast conserving surgery: The effect of age
98. Impact of young age on outcome in patients with ductal carcinoma in situ treated with breast-conserving therapy
99. Management of contralateral breast
100. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
101. Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast
102. Treatment of recurrent ductal carcinoma in situ
103. Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast